Efficacy and tolerability of dietary supplement Erostamin in patients with lower urinary tract symptoms and erectile dysfunction associated with BPH
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: the aim of this study was to evaluate the efficacy and tolerability of the dietary supplements (DS) Erostamin in patients with lower urinary tract symptoms and erectile dysfunction associated with BPH.
Patients and methods. In an open prospective study involved 30 patients with SHS and ED associated with BPH, aged 45 to 65 years. Patients within 60 days used 300 mg DD Eroscan (production of LLC «WORLD GRENZHAUSEN SYSTEMS») to 2 capsule 2 times a day.
Results. It was determined that the DS Erostamin effectively restore erectile function after treatment for two capsules twice a day for 60 days, there is a significant improvement in the integration parameters characterizing the sexual function and voiding in patients with ED and LUTS BPH, namely ICEF and and (IPSS, QoL). The frequency of adverse events was 13%, and they did not require discontinuation DS. No serious side effects were noted.
Conclusions. The two-month course of treatment DS Erostamin leads to a substantial and significant improvement of MІEF and IPSS, QoL in patients with erectile dysfunction and lower urinary tract symptoms of BPH in the background. Erostamin has the highest rate of compliance, without causing serious side effects with prolonged use (within 60 days).
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Горпинченко И.И. Эректильная дисфункция: диагностика и современные методы лечения // Здоровье мужчины. – No 1, 2002. – С. 9–11.
Горпинченко И.И., Мирошников Я.О. Эректильная дисфункция. – Л., «Медицина світу», 2003.
Горпинченко И.И. Геронтологическая сексопатология: Производственное издание. – Здоровья, 1991. – 168 с.
Вагнер Г., Грин Р. Импотенция (физиология, психология, хирургия, диагностика и лечение). – М.: Медицина, 1985. – 240 с.
Сексология и андрология / Под ред. А.Ф. Возианова, И.И. Горпинченко. – К.: Абрис, 1997. – 880 с.
Пасечников С.П., Никитин О.Д. Клиническое исследование эффективности и безопасности препарата Трибестан в лечении эректильной дисфункции // Здоров’я України. – 2008. – No 4. – С. 50–51.
Capelleri J.C., Rosen R.C., Smith M.D., Quirk F., Maytom M.C., Mishra A., Osterloh I.H. Some developments on the International Index of Erectile Dysfunction (IIEF) // Drug Information Journal, 1999. – Vol. 33. – Р. 179–190.
Rosen R.C., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction // Urology. – 1997. – V. 49. – P. 822–830.
Ang H.H., Ngai T.H., Tan T.H. Effects of Eurycoma longifolia Jack on sexual qualities in middle aged male rats. Phytomedicine. 2003;10:590–593.
Романюк М.Г., Корнієнко О.М. Еростамін – ефективний фітопрепарат для лікування статевих розладів у чоловіків //«Здоровье мужчины, 2 (33). – 2010.
Методичні рекомендації з клінічних випробувань лікарських засобів в Україні. – К.: МОРІОН, 1999. – С. 1–74.
Гланц С. Медико-биологическая статистика. Пер. с англ. – М.: Практика, 1998. – 459 с.
